(Q38084325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Richard B. Warren

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

U Mrowietz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

E M G J de Jong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

K Kragballe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

R Langley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

A Nast

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

K Reich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J Schmitt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

26 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

Journal of the European Academy of Dermatology and Venereology

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

438-453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23437792%20AND%20SRC:MED&resulttype=core&format=json

Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.

24 February 2020

cites work

1 reference

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

21 January 2018

1 reference

S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.

21 January 2018

1 reference

German S3-guidelines on the treatment of psoriasis vulgaris (short version).

21 January 2018

1 reference

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

21 January 2018

1 reference

Definition of treatment goals for moderate to severe psoriasis: a European consensus

21 January 2018

1 reference

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey

21 January 2018

1 reference

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group

21 January 2018

1 reference

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

21 January 2018

1 reference

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

21 January 2018

1 reference

Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.

21 January 2018

1 reference

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

21 January 2018

1 reference

Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.

21 January 2018

1 reference

The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.

21 January 2018

1 reference

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.

21 January 2018

1 reference

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

21 January 2018

1 reference

Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis

21 January 2018

1 reference

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).

21 January 2018

1 reference

Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study.

21 January 2018

1 reference

Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity

21 January 2018

1 reference

Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.

21 January 2018

1 reference

Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years

21 January 2018

1 reference

Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent

21 January 2018

1 reference

Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up

21 January 2018

1 reference

Etanercept combined with methotrexate for high-need psoriasis

21 January 2018

1 reference

The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.

21 January 2018

1 reference

Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland.

21 January 2018

1 reference

Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial

21 January 2018

1 reference

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy

21 January 2018

1 reference

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.

21 January 2018

1 reference

Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study

21 January 2018

1 reference

Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.

21 January 2018

1 reference

Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy.

21 January 2018

1 reference

A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project.

21 January 2018

1 reference

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

21 January 2018

1 reference

Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor alpha biologics and switched to ustekinumab.

21 January 2018

1 reference

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

21 January 2018

1 reference

A framework for improving the quality of care for people with psoriasis

21 January 2018

1 reference

Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies

21 January 2018

1 reference

A clinical trial of combination therapy with etanercept and low dose cyclosporine for the treatment of refractory psoriasis

21 January 2018

1 reference

Adalimumab treatment for severe recalcitrant chronic plaque psoriasis

21 January 2018

1 reference

https://api.fatcat.wiki/v0/release/wa6wcmkjizbjbhehid2mr4fwsq

21 January 2018

Identifiers

1 reference

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_wa6wcmkjizbjbhehid2mr4fwsq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wa6wcmkjizbjbhehid2mr4fwsq

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/wa6wcmkjizbjbhehid2mr4fwsq

1 reference